ATLANTA — Researchers at the University of California San Francisco report that melanoma patients whose cancer has spread to their sentinel lymph nodes (SLNs) have a greater chance of experiencing disease recurrence and mortality compared to those whose cancer has not advanced to their SLNs.
2024
The Spot sends a message to Australians about skin cancer and melanoma
Bristol Myers Squibb is proud to have partnered with La Roche-Posay, Ogilvy and Sculpture by the Sea on The Spot to highlight to Australians that prevention and early disease detection is the best way to tackle skin cancer and melanoma.
Melanoma Mortality Rises at 0.8-mm Breslow Thickness, Study Finds
The risk for melanoma-related death was higher in individuals with tumors with a Breslow thickness of 0.8-1.0 mm than in individuals with tumors smaller than 0.8 mm, in an Australian study that used registry data.
2024 Breakthroughs in Skin Cancer
Discover 2024 skin cancer breakthroughs, including FDA approvals, innovative therapies, and updated clinical guidelines for melanoma and nonmelanoma care.